Welgene Biotech Co.,Ltd. (TPEX:6661)

Welgene Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	415	433	555	521	517	570
Market Cap Growth	-21.93%	-21.85%	6.49%	0.68%	-9.20%	-23.98%
Enterprise Value	378	350	499	500	317	410
Last Close Price	17.80	18.60	23.80	22.35	22.02	23.69
PE Ratio	311.89	325.91	501.03	-	54.16	41.58
PS Ratio	1.10	1.15	1.72	1.86	1.61	1.82
PB Ratio	1.45	1.52	1.88	1.74	1.70	1.84
P/TBV Ratio	1.48	1.54	1.93	1.79	1.71	1.85
P/FCF Ratio	-	-	10.82	-	21.06	82.94
P/OCF Ratio	11.76	12.29	9.89	-	10.06	50.67
EV/Sales Ratio	1.01	0.93	1.55	1.78	0.99	1.31
EV/EBITDA Ratio	13.58	12.55	34.31	52.76	12.97	18.46
EV/EBIT Ratio	-	2758.71	-	-	18.34	28.69
EV/FCF Ratio	-62.27	-	9.73	-	12.90	59.72
Debt / Equity Ratio	0.79	0.79	0.44	0.51	0.17	0.08
Debt / EBITDA Ratio	8.11	8.11	4.66	6.77	1.42	0.72
Debt / FCF Ratio	-	-	2.53	-	2.08	3.47
Net Debt / Equity Ratio	-0.14	-0.14	-0.33	-0.14	-0.55	-0.64
Net Debt / EBITDA Ratio	-1.46	-1.46	-6.65	-4.51	-6.81	-8.98
Net Debt / FCF Ratio	6.72	6.72	-1.88	1.52	-6.77	-29.06
Asset Turnover	0.65	0.65	0.60	0.57	0.75	0.80
Inventory Turnover	5.79	5.79	4.12	3.67	5.91	7.91
Quick Ratio	1.92	1.92	2.02	1.93	2.53	2.72
Current Ratio	2.21	2.21	2.34	2.39	2.89	2.99
Return on Equity (ROE)	0.45%	0.45%	0.24%	-1.04%	3.11%	4.87%
Return on Assets (ROA)	0.01%	0.01%	-0.10%	-0.54%	2.51%	2.28%
Return on Invested Capital (ROIC)	0.06%	0.06%	-0.21%	-2.16%	9.82%	11.18%
Return on Capital Employed (ROCE)	0.00%	0.00%	-0.20%	-1.00%	5.20%	4.60%
Earnings Yield	0.32%	0.31%	0.20%	-0.51%	1.85%	2.40%
FCF Yield	-1.46%	-1.40%	9.24%	-5.39%	4.75%	1.21%
Dividend Yield	-	-	-	-	0.82%	2.03%
Payout Ratio	-	-	-	-	118.16%	187.38%
Buyback Yield / Dilution	4.88%	4.88%	-	0.10%	-0.93%	-10.99%
Total Shareholder Return	4.88%	4.88%	-	0.10%	-0.11%	-8.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.